CAT. NO.: AMA-0089
Target Information | |
---|---|
UniProt ID | Q15831 |
Product Details | |
---|---|
Size | 100 μL |
Reactivity | Human, Monkey |
Host | Rabbit |
Source/Isotype | Rabbit IgG |
Storage | Store at -20°C. |
Purification | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of human LKB1. |
Usage | |
---|---|
Application | WB, IP |
Product Usage Information Dilution | Western Blotting (1:1000); Immunoprecipitation (1:100) |
MW (Target) | 54 kDa |
Background | |
---|---|
LKB1 (STK11) is a serine/threonine kinase and tumor suppressor that helps control cell structure, apoptosis and energy homeostasis through regulation of numerous downstream kinases. A cytosolic protein complex comprised of LKB1, putative kinase STRAD, and the MO25 scaffold protein, activates both AMP-activated protein kinase (AMPK) and several AMPK-related kinases. AMPK plays a predominant role as the master regulator of cellular energy homeostasis, controlling downstream effectors that regulate cell growth and apoptosis in response to cellular ATP concentrations. LKB1 appears to be phosphorylated in cells at several sites, including human LKB1 at Ser31/325/428 and Thr189/336/363.Mutation in the corresponding LKB1 gene causes Peutz-Jeghers syndrome (PJS), an autosomal dominant disorder characterized by benign GI tract polyps and dark skin lesions of the mouth, hands, and feet. A variety of other LKB1 gene mutations have been associated with the formation of sporadic cancers in several tissues. |
Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.